BATON ROUGE, La., Sept. 26 Albemarle Corporation
(NYSE: ALB), a global supplier of the active pharmaceutical ingredient
Ibuprofen, will increase the price of its Ibuprofen 40 micron and Ibuprofen 70
micron products by 12 percent, and its Ibuprofen 20 micron product by 20
percent, worldwide, effective October 15, 2007, or as contracts allow.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )
"Albemarle proudly stands behind its quality record, which is supported
through decades of outstanding FDA inspection performance at our plant in
Orangeburg, South Carolina," said Brian Carter, Global Business Manager,
Pharmaceutical Actives. "This price increase will allow us to continue to
supply the industry with a consistent, reliable supply of what we believe is
the highest quality Ibuprofen available on the market today."
Albemarle Corporation, headquartered in Richmond, Virginia, is a leading
global developer, manufacturer and marketer of highly engineered specialty
chemicals for petroleum and petrochemical processing; transportation and
industrial products; consumer electronics; pharmaceuticals; agricultural
products; and construction and packaging materials. The Company operates in
three business segments, Polymer Additives, Catalysts and Fine Chemicals, and
serves customers in approximately 100 countries. For more information about
Albemarle, please visit www.albemarle.com.
ALBEMARLE is a registered trademark of Albemarle Corporation.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act
of 1995: Statements in this press release regarding Albemarle Corporation's
business which are not historical facts are "forward-looking statements" that
involve risks and uncertainties. For a discussion of such risks and
uncertainties, which could cause actual results to differ from those contained
in the forward-looking statements, see "Risk Factors" in the Company's Annual
Report on Form 10-K.
SOURCE Albemarle Corporation
Category:
